Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine with Ketamine or Dexmedetomidine in Pelvi-abdominal Cancer Surgery
NCT06631625Phase 1Completed
- Sponsor
- Alexandria University
- Start
- Sep 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ketamine and dexmedetomidine in pain (3 arms), sponsored by Alexandria University. Primary endpoint: Serum pro-inflammatory cytokines (IL-1, IL-6, TNFα). Started Sep 2023; status: completed.
02
Drugs
ketaminedexmedetomidine
03
Conditions
pain
Beyond the preview
Go deeper on NCT06631625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06631625.